/product/antibody-drug-conjugates-adc-seattle-genetics-inc-nasdaq-2001-6725.html

At Investor Conferences

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2022 650x100
Product › Details

antibody-drug conjugates (ADC) technology

Products Next higher product group drug development technology
Period Status  unspecified existent
Organisation Organisation Seattle Genetics Inc. (Nasdaq: SGEN)
  Today Seagen Inc. (Nasdaq: SGEN)
  Group Seagen (Group)
     

   
Record changed: 2022-09-06

Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

More documents for antibody-drug conjugates (ADC) technology


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x300px




» top